This is a case, believe it or not, where the drug company's product
information supports breastfeeding--yet both the pharmacist and the doctor
missed it:

After ophthalmic instillation, trifluridine excretion in human breast milk
is unlikely due to the relatively small dose administered, the dilution in
body fluids, and the very short half-life (Product Information Viroptic (R),
1998).

Whenever one is dealing with ophthalmics and breastfeeding, in MOST cases,
the above is true, and MOST ophthalmics can be used while breastfeeding.

Frank J. Nice, DPA, CPHP

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html